Synthesis and Structure−Activity Relationships of Amide and Hydrazide Analogues of the Cannabinoid CB1 Receptor Antagonist N-(Piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716)-Reference-Cited by-同舟云学术

Synthesis and Structure−Activity Relationships of Amide and Hydrazide Analogues of the Cannabinoid CB1 Receptor Antagonist N-(Piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716)

Published:2002-05-18 Issue:13 Volume:45 Page:2708-2719
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Francisco Ma. Elena Y.¹,Seltzman Herbert H.¹,Gilliam Anne F.¹,Mitchell René A.¹,Rider Sharyl L.¹,Pertwee Roger G.¹,Stevenson Lesley A.¹,Thomas Brian F.¹

Affiliation:

1. Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, North Carolina 27709, and Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm010498v

Reference37 articles.

1. An Improved Method of Calculating Spin Properties from Spin-Polarized Wave Functions

2. Chemical Basis of Hashish Activity

3. A cannabinoid derived prototypical analgesic

4. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Pyrazolesulfoximines Using α-Diazosulfoximines with Alkynes;Organic Letters;2024-02-02

2. A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery;Molecules;2023-12-15

3. Phosphine-catalyzed ring-opening reaction of cyclopropenones with dicarbonyl compounds;Organic & Biomolecular Chemistry;2023

4. Carbohydrazide analogues: a review of synthesis and biological activities;Mini-Reviews in Medicinal Chemistry;2021-08-31

5. From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis;Journal of Medicinal Chemistry;2020-12-31